Page last updated: 2024-12-05

2,5-di-tert-butylbenzoquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID17161
CHEMBL ID3560130
CHEBI ID183272
SCHEMBL ID49783
MeSH IDM0184623

Synonyms (60)

Synonym
CHEBI:183272
2,5-ditert-butylcyclohexa-2,5-diene-1,4-dione
2,5-ditert-butyl-[1,4]benzoquinone
AKOS015837828
2460-77-7
p-benzoquinone,5-di-tert-butyl-
nsc7489
nsc-7489
2,5-di-tert-butylsemiquinone
2,4-dione, 2,5-bis(1,1-dimethylethyl)-
2,5-di-tert-butylbenzoquinone
2,5-di-tert-butylquinone
nsc-43579
nsc43579
p-benzoquinone, 2,5-di-tert-butyl-
ai3-16635
einecs 219-552-0
2,5-bis(1,1-dimethylethyl)-2,5-cyclohexadiene-1,4-dione
2,5-cyclohexadiene-1,4-dione, 2,5-bis(1,1-dimethylethyl)-
nsc 43579
2,5-di-tert-butyl-1,4-benzoquinone
brn 2047945
2,5-di-t-butyl-p-benzoquinone
2,5-di-tert-butyl-p-benzoquinone
2,5-cyclohexadien-1,4-dione, 2,5-bis(1,1-dimethylethyl)-
nsc 7489
hsdb 3931
2,5-di-tert-butyl-1,4-benzoquinone, 99%
MAYBRIDGE4_002986
NCGC00176338-01
HMS1529H16
2,5-di-tert-butyl-p-quinone
D0178
zzyasvwwdljxim-uhfffaoysa-
inchi=1/c14h20o2/c1-13(2,3)9-7-12(16)10(8-11(9)15)14(4,5)6/h7-8h,1-6h3
NCGC00176338-02
CCG-1811
unii-g893osv02d
g893osv02d ,
2,5-di-tert-butylcyclohexa-2,5-diene-1,4-dione
A817394
FT-0610493
SCHEMBL49783
2,5-di-t-butyl-1,4-benzoquinone
dtxsid3044889 ,
NCGC00357046-01
tox21_303738
dtxcid1024889
cas-2460-77-7
2,5-ditert-butylbenzo-1,4-quinone
ZZYASVWWDLJXIM-UHFFFAOYSA-N
CHEMBL3560130
mfcd00019442
J-015589
CS-W023258
AS-15434
2,5-di-tert-butyl-1,4-quinone
D71098
Q27278928
SY049950
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
p-quinonesA quinone in which the two oxo groups of the quinone are located para to each other on the 6-membered quinonoid ring.
benzoquinonesAny quinone resulting from the formal oxidation of catechol, hydroquinone, or their C-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency19.49710.002541.796015,848.9004AID1347395
RAR-related orphan receptor gammaMus musculus (house mouse)Potency10.39160.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency8.05330.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency21.13170.000221.22318,912.5098AID1259243; AID1259247
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency26.60320.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency17.62580.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency7.49780.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency4.76540.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency21.13170.001530.607315,848.9004AID1224841; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency18.83360.005428.02631,258.9301AID1346982
thyroid stimulating hormone receptorHomo sapiens (human)Potency9.81570.001628.015177.1139AID1224843; AID1224895
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1374918Growth inhibition of human A2780 cells after 72 hrs by SRB assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID1592252Inhibition of Schistosoma mansoni DHODH assessed as remaining enzyme activity at 500 uM using DHO as substrate measured at 4 secs interval for 60 secs by DCIP reduction based indirect assay relative to control2019European journal of medicinal chemistry, Apr-01, Volume: 167Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.
AID1374922Antiplasmodial activity against Plasmodium falciparum Dd2 by SYBR Green I fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID1374921Selectivity index, ratio of IC50 for SV-40 immortalized human ovarian epithelial cells to IC50 for human A2780cis cells2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID1374919Growth inhibition of human OVCAR8 cells after 72 hrs by SRB assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID1374928Growth inhibition of SV-40 immortalized human ovarian epithelial cells after 72 hrs by SRB assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
AID1374920Growth inhibition of human A2780cis cells after 72 hrs by SRB assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's14 (66.67)18.2507
2000's2 (9.52)29.6817
2010's5 (23.81)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.89 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]